IPO Guru
Bajaj
Listed

Sudeep Pharma IPO GMP History

Sudeep Pharma IPO has been listed on November 28, 2025 at a listing price of ₹730, against the issue price of ₹593 — a gain of ₹137 (+23.1%). The GMP peaked at ₹130 on 20 November 2025 and reached a low of ₹85 on 27 November 2025. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.

Sudeep Pharma IPO raised ₹895 Cr. through its IPO at a price band of ₹563 to ₹593 per share, with a lot size of 25 shares. The IPO was open for subscription from 21 Nov 2025 to 25 Nov 2025.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

GMP trend

Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 3 Sep, 2:08 PM IST.

Peak GMP
₹130
20 Nov 2025
Lowest GMP
₹85
27 Nov 2025
Direction
▲ rising
₹115 on 28 Nov vs ₹85 on 26 Nov

Day-wise GMP

The last reading of each day, newest first. Arrows compare with the previous day.

Date GMP ↑↓ % Kostak Sub. Sauda
28 Nov 2025 ₹ 115 ▲ 19% — —
27 Nov 2025 ₹ 85 — 14% — —
26 Nov 2025 ₹ 85 — 14% — —
25 Nov 2025 ₹ 85 ▼ 14% — —
24 Nov 2025 ₹ 115 ▲ 19% — —
22 Nov 2025 ₹ 112 ▼ 19% — —
21 Nov 2025 ₹ 118 ▼ 20% — —
20 Nov 2025 ₹ 130 ▲ 22% — —
19 Nov 2025 ₹ 93 — 16% — —

Sudeep Pharma IPO dates

Key dates from opening to listing. Today is 23 November.

Key dates Listed
  1. Open 21 Nov 2025
  2. Close 25 Nov 2025
  3. Allotment 26 Nov 2025
  4. Refund/credit 27 Nov 2025
  5. Listing 28 Nov 2025

Sudeep Pharma IPO actual listing price

How the grey market's final call compared with the listing-day open.

Issue price₹593
GMP-based estimate (pre-listing)₹686 (+15.7%)
Listing gain / loss +₹137 per share
Listing date28 Nov, 2025
Actual listing price ₹730 (+23.1%)

Is Sudeep Pharma IPO GMP reliable?

Grey market premium for Sudeep Pharma IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:

  • 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
  • 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
  • 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
  • 04Cross-check before acting: Review the Sudeep Pharma IPO full review for a fundamentals-based assessment before making any grey market trades.

Sudeep Pharma IPO Kostak rate explained

Two ways the grey market trades an IPO application before listing.

Kostak
Not available

The Kostak rate for Sudeep Pharma IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.

Subject to Sauda
Not available

The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.

Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.

About Sudeep Pharma IPO

Sudeep Pharma Limited is an India-based pharmaceutical company known for its specialization in mineral-based excipients and active ingredients used across pharma, nutraceutical, and food industries. Established with a focus on quality and innovation, the company has built a strong presence over the years by catering to both domestic and international markets. Promoted by experienced industry professionals, Sudeep Pharma has developed deep technical expertise and a reputation for consistent product standards, regulatory compliance, and customer-centric operations.

The company primarily manufactures calcium-based and mineral ingredients such as calcium carbonate, calcium citrate, and other specialty compounds widely used in tablets, dietary supplements, and fortified food products. Its business model is largely B2B, supplying to pharmaceutical companies, nutraceutical brands, and global distributors. By focusing on quality certifications, scalable manufacturing, and long-term client relationships, the company aims to sustain growth and expand its footprint in regulated and semi-regulated markets worldwide.

View full IPO details →

Frequently asked

What is the GMP of Sudeep Pharma IPO?

The current Grey Market Premium (GMP) of Sudeep Pharma IPO is ₹ 93.

What is the Kostak Price of Sudeep Pharma IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Sudeep Pharma IPO is not available.

What is the Subject to Sauda Price of Sudeep Pharma IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.

What was the actual listing price of Sudeep Pharma IPO?

Sudeep Pharma IPO listed on November 28, 2025 at ₹730, against the issue price of ₹593 — a gain of +23.1%.

How did the GMP of Sudeep Pharma IPO trend before listing?

The GMP of Sudeep Pharma IPO was rising in its final days before listing. The GMP peaked at ₹130 on 20 November 2025. View the day-wise table above for the complete GMP history.

Explore Sudeep Pharma IPO further

The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.

Sudeep Pharma IPO GMP

The grey market called it. Now check the fundamentals.

IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.

Join the WhatsApp channel All live IPO GMP

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹ 93
Kostak
—
Listed at
₹730
Full IPO details
Advertisement